Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
Despite the available antibiotics, tuberculosis (TB) has made its return since the 90’s of the last century as a global threat mostly due to co-infection with HIV, to the emergence of drug resistant strains and the lack of an effective vaccine. Host-directed strategies could be exploited to improve...
Main Authors: | David Pires, Sofia Valente, Marta Calado, Manoj Mandal, José Miguel Azevedo-Pereira, Elsa Anes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.647728/full |
Similar Items
-
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
by: Stephan C, et al.
Published: (2010-09-01) -
No-modified saquinavir is equally efficient against doxorubicin sensitive and resistant non-small cell lung carcinoma cells
by: Mijatović Sanja, et al.
Published: (2013-01-01) -
Efeito in vitro do saquinavir isolado e em combinação com o itraconazol frente a cepas de histoplasma capsulatum var. capsulatum
by: Pereira, Juliana Fernandes
Published: (2015) -
Desenvolvimento e caracterização de nanocápsulas poliméricas contendo saquinavir planejadas para administração oral
by: Emanuelli, Juliana
Published: (2016) -
Desenvolvimento e caracterização de nanocápsulas poliméricas contendo saquinavir planejadas para administração oral
by: Emanuelli, Juliana
Published: (2016)